Efficacy and Safety Phase II Study of SR-T100 to Treat Actinic Keratosis

NCT ID: NCT01516515


Title
A Double-blind, Randomized, Vehicle-controlled, Parallel-group, Phase II Study to Evaluate the Efficacy and Safety of SR-T100 Gel in Patients With Actinic Keratosis (AK)
Purpose
This Phase II study is to evaluate the efficacy of SR-T100 gel with 2.3% of SM in Solanum undatum plant extract in patient with Actinic Keratosis (AK).
Details
Conditions
Actinic Keratosis
Keywords
Actinic Keratosis, AK
Source
G&E Herbal Biotechnology Co., LTD
Sponsors
G&E Herbal Biotechnology Co., LTD
Status
Recruiting
Acronym
Last Updated
16 Feb 2016
URL
Official Link
Locations
United States